| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 76, 1391-1396, Copyright © 1993 by Endocrine Society
ARTICLES |
HG Burger
Prince Henry's Institute of Medical Research, Monash Medical Centre, Clayton, Victoria, Australia.
New and specific assays, probably based on two-site assay technology, for various forms of circulating gonadal peptides are likely to be available within the next few years and these in turn should open up a range of potential clinical applications, particularly in andrology, management of ovulatory disorders, and especially ovarian and perhaps other malignancies. Current inhibin assays are already proving to be of great value in ovarian cancer management. The recent demonstration that inhibin subunits and dimeric activin are present in the human adrenal also raises the possibility that measurement of inhibin and activin may ultimately be applicable to the study of adrenal disorders.
This article has been cited by other articles:
 |
|
 |
|
  C. H. Gravholt, R. W. Naeraa, A.-M. Andersson, J. S. Christiansen, and N. E. Skakkebaek Inhibin A and B in adolescents and young adults with Turner's syndrome and no sign of spontaneous puberty Hum. Reprod., August 1, 2002; 17(8): 2049 - 2053. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Fawzy, A. Lambert, R.F. Harrison, P.G. Knight, N. Groome, B. Hennelly, and W.R. Robertson Day 5 inhibin B levels in a treatment cycle are predictive of IVF outcome Hum. Reprod., June 1, 2002; 17(6): 1535 - 1543. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Gokyar, A. Kokcu, F. Yanik, M. B. Cetinkaya, T. Alper, and E. Malatyalioglu Basal and day 12 inhibin concentrations in the prediction of ovarian response to gonadotrophins in women with PCOS Hum. Reprod., October 1, 2001; 16(10): 2079 - 2083. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. von Eckardstein, M. Simoni, M. Bergmann, G. F. Weinbauer, P. Gassner, A. G. Schepers, and E. Nieschlag Serum Inhibin B in Combination with Serum Follicle-Stimulating Hormone (FSH) Is a More Sensitive Marker Than Serum FSH Alone for Impaired Spermatogenesis in Men, But Cannot Predict the Presence of Sperm in Testicular Tissue Samples J. Clin. Endocrinol. Metab., July 1, 1999; 84(7): 2496 - 2501. [Abstract] [Full Text]
|
|
|
|
|
|
H. G. Burger, N. P. Groome, and D. M. Robertson Both Inhibin A and B Respond to Exogenous Follicle-Stimulating Hormone in the Follicular Phase of the Human Menstrual Cycle J. Clin. Endocrinol. Metab., November 1, 1998; 83(11): 4167 - 4169. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. C. Prior Perimenopause: The Complex Endocrinology of the Menopausal Transition Endocr. Rev., August 1, 1998; 19(4): 397 - 428. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. J. Hayes, J. E. Hall, P. A. Boepple, and W. F. Crowley Jr. Differential Control of Gonadotropin Secretion in the Human: Endocrine Role of Inhibin J. Clin. Endocrinol. Metab., June 1, 1998; 83(6): 1835 - 1841. [Full Text]
|
|
|
|
|
|
E. M. Wallace, N. P. Groome, S. C. Riley, A. C. Parker, and F. C. W. Wu Effects of Chemotherapy-Induced Testicular Damage on Inhibin, Gonadotropin, and Testosterone Secretion: A Prospective Longitudinal Study J. Clin. Endocrinol. Metab., September 1, 1997; 82(9): 3111 - 3115. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
